Browse "Graduate School of Medical Science & Engineering(의과학대학원)" by Subject NIVOLUMAB

Showing results 1 to 9 of 9

1
Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors

Kang, Da Hyun; Park, Cheol-Kyu; Chung, Chaeuk; Oh, In-Jae; Kim, Young-Chul; Park, Dongil; Kim, Jinhyun; et al, IMMUNE NETWORK, v.20, no.3, 2020-06

2
Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients

Son, Seung-Myoung; Woo, Chang Gok; Kim, Dae Hoon; Yun, Hyo Yung; Kim, Hongsik; Kim, Hee Kyung; Yang, Yaewon; et al, SCIENTIFIC REPORTS, v.10, no.1, pp.14293, 2020-08

3
Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma

Park, Junseong; Kim, Chang Gon; Shim, Jin-Kyoung; Kim, Jong Hoon; Lee, Hoyoung; Lee, Jae Eun; Kim, Min Hwan; et al, ONCOIMMUNOLOGY, v.8, no.1, 2019-01

4
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

Kim, C. G.; Kim, K. H.; Pyo, K-H; Xin, C-F; Hong, M. H.; Ahn, B-C; Kim, Y.; et al, ANNALS OF ONCOLOGY, v.30, no.7, pp.1104 - 1113, 2019-07

5
Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8(+) T Cells is Determined by Their Differentiation Status in Glioblastoma

Park, Junsik; Kwon, Minsuk; Kim, Kyung Hwan; Kim, Tae-Shin; Hong, Seon-Hui; Kim, Chang Gon; Kang, Seok-Gu; et al, CLINICAL CANCER RESEARCH, v.25, no.8, pp.2549 - 2559, 2019-04

6
Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment

Kim, Kyung Hwan; Hur, Joon Young; Cho, Jinhyun; Ku, Bo Mi; Koh, Jiae; Koh, June Young; Sun, Jong-Mu; et al, ONCOIMMUNOLOGY, v.9, no.1, 2020-01

7
Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response

Kim, Chang Gon; Koh, June-Young; Shin, Su-Jin; Shin, Ji-Hee; Hong, Moonki; Chung, Hyun Cheol; Rha, Sun Young; et al, CELL REPORTS MEDICINE, v.4, no.11, 2023-11

8
The First-week Proliferative Response of Peripheral Blood PD-1(+)CD8(+) T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors

Kim, Kyung Hwan; Cho, Jinhyun; Ku, Bo Mi; Koh, Jiae; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; et al, CLINICAL CANCER RESEARCH, v.25, no.7, pp.2144 - 2154, 2019-04

9
Tumour-infiltrating bystander CD8(+) T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer

Leem, Galam; Jeon, Minwoo; Kim, Kun Woo; Jeong, Seongju; Choi, Seong Jin; Lee, Yong Joon; Kim, Eui-Soon; et al, THORAX, v.77, no.8, pp.769 - 780, 2022-08

Discover

rss_1.0 rss_2.0 atom_1.0